Groupement Hospitalier Sud - Service de Médecine Gériatrique
Pierre-Bénite, 69495, France
NCT Number: NCT02199912
Cachexia associated with cancer is a grave and most of the time irreversible common situation. It seems independent from the size of the tumor or from its metastatic character. The consequences for the management of the patient are major and exceed widely the frame of the nutrition.
Undernutrition of patients with cancer is described by a decrease of the energy contributions and a loss of muscular and fat mass, leading to a progressive functional deficiency which can go to the cachectic state.
Actually, clinical criteria are proposed allowing to characterize the state of pre-cachexia but it remain too indistinct to allow an early and efficient screening and set up effective measures of prevention of the cachexia, to avoid the loss of muscular tissue and the cast iron of the energy reserves.
It is necessary to have clinical and biological markers with diagnostic aim and forecasts during the situations precedents the appearance of cachexia.
The present study will allow calibrating a longitudinal study, which could confirm the value of measures made for the diagnosis of pre-cachexia.
Looking for future studies?
Notify Me70 year and older
All sexes
Interventional
Not applicable
Pierre-Bénite, 69495, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of physical composition (non-invasive method)
Nutritional status will be assessed by using the "Mini Nutritional Assessment" (MNA) questionnaire and a scale that evaluates anorexia
This will be assessed by using a "tiredness scale" named "Echelle Visuelle Analogique" (EVA) in french
Muscular strength will be assessed thanks to the Handgrip Strength Test and the Short Physical Performance Battery (SPPB)
The emotional status wil be assessed thanks to the Yesavage Geriatric Depression Scale (GDS)
The functional status will be assessed by using the Activity of Daily Life (ADL) questionnaire and the Instrumental Activities of Daily Living (IADL) Questionnaire
Time frame: During perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days)
Validated criteria of cachexia, pre-cachexia and sarcopenia are applied. Systematic preoperative measures (TNFα, leptin, ghrelin) and CT scanning of the abdomen/pelvis are performed for all patient enrolled.
Time frame: During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)
The activity of ATGL is determined by liquid scintillation counting.
Time frame: During perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days)
Body composition is evaluated utilizing computerized tomography(CT) images (at the third lumbar vertebral level). A muscle index is also calculated by normalizing muscle areas for height.
Time frame: During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)
metabolic phenotype is determinated by indirect calorimetry.
Time frame: During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days)
Lean body mass and components (intracellular water and extracellular water as well as body cell mass) were calculated by tetrapolar bioelectrical impedance analysis
Hospices Civils de Lyon
Other
ANC2 Pilot Study Study of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal Surgery
Acronym: ANC2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00199862
Colonic Diseases, Colorectal Cancer
New York, United States
View Trial DetailsNCT00040599
Colon Cancer, Colonic Diseases
Newport Beach, California, United States
View Trial DetailsNCT00437268
Colonic Diseases, Colorectal Cancer
Casa Grande, Arizona, United States
View Trial DetailsNCT00606944
Colonic Diseases, Colorectal Neoplasms
Seongnam, South Korea
View Trial Details